However, our study showed that the percentages of CD38+ B cells and CD38+CD95+ B cells were significantly increased in active SLE patients, although there was no difference in the percentage of CD95+ B cells between SLE patients and normal controls. This evidence concerns the gene CD38 and systemic lupus erythematosus.